Ardelyx | ARDX - Cost Of Sales

Stock Price
7.34
Daily Change
0.34 4.86%
Monthly
25.90%
Yearly
31.54%
Q1 Forecast
7.45

Ardelyx reported $3.98M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Abbott USD 4.92B 535M Dec/2025
Amgen USD 1.79B 128M Dec/2025
Ardelyx USD 3.98M 10.84M Sep/2025
aTyr Pharma USD 22.13M 6.75M Sep/2025
Corcept Therapeutics USD 4.6M 1.16M Sep/2025
Sanofi EUR 3.76B 344M Dec/2025
TG Therapeutics USD 28.09M 9.15M Sep/2025
United Therapeutics USD 100.9M 74.3M Sep/2025